Stereotactic body radiation therapy for locally recurrent, previously irradiated nonsquamous cell cancers of the head and neck

Head and Neck

Volumn 34, Issue 8, 2012, Pages 1153-1161

  Vargo, John A ^a,b   Wegner, Rodney E ^a   Heron, Dwight E ^a   Ferris, Robert L ^a   Rwigema, Jean Claude M ^a   Quinn, Annette ^a   Gigliotti, Patricia ^a   Ohr, James ^a   Kubicek, Greg J ^a   Burton, Steven ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

head and neck cancer; stereotactic body radiation therapy (SBRT); stereotactic radiosurgery (SRS)

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ACINAR CELL CARCINOMA; ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; BASAL CELL CARCINOMA; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DYSGEUSIA; DYSPHAGIA; EDEMA; ESTHESIONEUROBLASTOMA; FATIGUE; FEMALE; HEAD AND NECK CANCER; HUMAN; LARYNX; MALE; MOUTH CAVITY; MUCOSA INFLAMMATION; MYOEPITHELIOMA; NASOPHARYNX; NONSQUAMOUS CELL CANCERS OF THE HEAD AND NECK; NOSE CAVITY; OROPHARYNX; OUTCOME ASSESSMENT; PAIN; PARANASAL SINUS; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE FRACTIONATION; RECURRENT CANCER; SALIVARY GLAND; SARCOMA; SKIN DISEASE; STEREOTACTIC BODY RADIATION THERAPY; THYROID CANCER; TOXICITY; TREATMENT FAILURE; TREATMENT PLANNING; TUMOR VOLUME; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DEGLUTITION DISORDERS; DYSGEUSIA; EDEMA; ESTHESIONEUROBLASTOMA, OLFACTORY; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUCOSITIS; MYOEPITHELIOMA; NEOPLASM RECURRENCE, LOCAL; OSTEONECROSIS; PAIN; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; QUALITY OF LIFE; RADIOSURGERY; RADIOTHERAPY DOSAGE; ROBOTICS; SARCOMA; SEVERITY OF ILLNESS INDEX; XEROSTOMIA;

EID: 84864280505     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21889     Document Type: Article

References (41)

1. Marur S, Forastiere AA,. Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc 2008; 83: 489-501.
2. Licitra L, Locati LD, Bossi P, Cantu G,. Head and neck tumors other than squamous cell carcinoma. Curr Opin Oncol 2004; 16: 236-241.
3. Lalami Y, Vereecken P, Deqaunter D, Lothaire P, Awada A,. Salivary gland carcinomas, paranasal sinus cancers and melanoma head and neck: an update about rare but challenging tumors. Curr Opin Oncol 2006; 18: 258-265.
4. Rosethal DI, Barker JL, El-Naggar Ak, et al. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Cancer 2004; 101: 2567-2573.
5. Spiro RH,. Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg 1997; 174: 495-498.
6. Resto VA, Chan AW, Deschler DG, Lin DT,. Extent of surgery in the management of locally advanced sinonasal malignancies. Cancer 2007; 30: 222-229.
7. Barnett TA, Kapp DS, Goffinet DR,. Management of recurrent, advanced, or persistent disease with hyperthermia and radiation therapy. Cancer 1990; 65: 2648-2656.
8. Taussky D, Dulguerov P, Allal AS,. Salvage surgery after radical accelerated radiotherapy with concomitant boost technique for head and neck carcinomas. Head Neck 2005; 27: 182-185.
9. Wong SJ, Machtay M, Li Y,. Locally recurrent, previously irradiated head and neck cancer: concurrent re-irradiation and chemotherapy, or chemotherapy alone? J Clin Oncol 2010; 24: 2653-2658.
10. Firlik KS, Kondziolka D, Lunsford LD, Janecka IP, Flickinger JC,. Radiosurgery for recurrent cranial base cancer arising from the head and neck. Head Neck 1996; 18: 160-166.
11. Lee N, Millender LE, Larson DA, et al. Gamma knife radiosurgery for recurrent salivary gland malignancies involving the base of skull. Cancer 2003; 25: 210-216.
12. Miller RC, Foote RL, Coffery RJ, et al. The role of radiosurgery in the treatment of malignant skull base tumors. Int J Radiat Oncol Biol Phys 1997; 39: 977-981.
13. Pai PC, Chuang CC, Wei KC, Tsang NM, Tseng CK, Chang CN,. Stereotactic radiosurgery for locally recurrent nasopharyngeal carcinoma. Head Neck 2002: 24; 748-753.
14. Chua DT, Sham JS, Kwong PW, Hung KN, Leung LH,. Linear accelerator-based stereotactic radiosurgery for limited, locally persistent, and recurrent nasopharyngeal carcinoma: efficacy and complications. Int J Radiat Oncol Biol Phys 2003; 56: 177-183.
15. Ryu S, Khan M, Yin FF, et al. Image-guided radiosurgery of head and neck cancers. Otolaryngol Head Neck Surg 2004; 130: 690-697.
16. Voynov G, Heron DE, Burton S, et al. Frameless stereotactic radiosurgery for recurrent head and neck carcinoma. Technol Cancer Res Treat 2006; 5: 529-535.
17. Roh KW, Jang JS, Kim MS, et al. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer. Int J Radiat Oncol Biol Phys 2009; 74: 1348-1355.
18. Siddiqui F, Patel M, Khan M, et al. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. Int J Radiat Oncol Biol Phys 2009; 74: 1047-1053.
19. Kawaguchi K, Sato K, Horie A, et al. Stereotactic radiosurgery may contribute to overall survival for patients with recurrent head and neck carcinomas. Radiat Oncol 2010; 5: 51 (abstract).
20. Cengiz M, Özyiǧit G, Yazici G, et al. Salvage reirradiation with stereotactic body radiotherapy for locally recurrent head-and-neck tumors. Int J Radiat Oncol Biol Phys 2010. [Epub ahead of print]
21. Unger KR, Lominska CE, Deeken JF, et al. Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2010; 18: 1411-1419.
22. Rwigema J-CM, Heron DE, Ferris RL, et al. Fractionated stereotactic body radiation therapy in the treatment of previously irradiated recurrent head and neck carcinoma. Am J Clin Oncol 2010; 33: 286-293.
23. Weymuller EA Jr, Alsarraf R, Yued B, Deleyiannis FW, Coltera MD,. Analysis of the performance characteristics of the University of Washington Quality of Life instrument and its modification (UW-QOL-R). Arch Otolaryngol Head Neck Surg 2001; 127: 489-493.
24. Andrade RS, Heron DE, Degirmenci B, et al. Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 2006; 65: 1315-1322.
25. Heron DE, Ferris RL, Karamouzis M, et al. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial. Int J Radiat Oncol Biol Phys 2009; 75: 1493-1500.
26. Tsuchida Y, Therasee P,. Response evaluation criteria in solid tumors (RECIST): new guidelines. Med Pediatr Oncol 2001; 37: 1-3.
27. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
28. Rwigema J-CM, Heron DE, Ferris RL, et al. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy. Am J Clin Oncol 2010 Sep 20. [Epub ahead of print]
29. Kodani N, Yamzaki H, Tsubokura T, et al. Stereotactic body radiation therapy for head and neck tumor: disease control and morbidity outcomes. J Radiat Res 2011; 52: 24-31.
30. Salama JK, Vokes EE,. Concurrent chemotherapy and re-irradiation for locoregionally recurrent head and neck cancer. Semin Oncol 2008; 35: 251-261.
31. Gokhale AS, Lavertu P,. Surgical salvage after chemoradiation of head and neck cancer: complications and outcomes. Curr Oncol Rep 2001; 3: 72-76.
32. Spencer SA, Harris J, Wheeler RH, et al. RTOG 96-10: reirradiation with concurrent hyrodyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys 2001; 51: 1299-1304.
33. Schaefer U, Micke O, Schueller P, Willich N,. Recurrent head and neck cancer: retreatment of previously irradiated areas with combined chemotherapy and radiation therapy: results of a prospective study. Radiology 2000; 216: 371-376.
34. Langer CJ, Harris J, Horwitz EM, et al. Phase II study of low-dose paclitaxel and cisplatin in combination with split course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of radiation therapy oncology group protocol 9911. J Clin Oncol 2007; 25: 4800-4805.
35. Truong MT, Grillone G, Tschoe C, Chin L, Kachnic LA, Jalisi S,. Emerging applications of stereotactic radiotherapy in head and neck cancer. Neurosurg Focus 2009; 27:Art. E11.
36. Heron DE, Rwigema J-CM, Gibson MK, Burton SA, Quinn AE, Ferris RL,. Concurrent cetuximab with stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: a single institution matched case-control study. Am J Clin Oncol 2011; 34: 165-172.
37. Douglas JG, Koh WJ, Austin-Seymour M, Laramore GE,. Treatment of salivary gland neoplasms with fast neutron radiotherapy. Arch Otolaryngol Head Neck Surg 2003; 129: 944-948.
38. Pederson AW, Haraf DJ, Blair EA, et al. Chemoreirradiation for recurrent salivary gland malignancies. Radiother Oncol 2010; 95: 308-311.
39. Surakanti SG, Agulnik M,. Salivary gland malignancies: the role for chemotherapy and molecular targeted agents. Semin Oncol 2008; 35: 309-319.
40. Matsuba HM, Spector GJ, Thawley SE, Simpson JR, Mauney M, Pikul FJ,. Adenoid cystic salivary gland carcinoma: a histopathologic review of treatment failure patterns. Cancer 1986; 57: 519-524.
41. Chua DTT, Sham JST, Au GKH,. Induction chemotherapy with cisplatin and gemcitabine followed by reirradiation for locally recurrent nasopharyngeal carcinoma. Am J Clin Oncol 2005; 28: 464-471.